fb
X
X
Tired?
Unfocused?
Off your game?
Read our free, updated as of Mar 3, 2022, Dr K report on how to optimize your mind and body so you can boost your focus when trading the markets.
YES, SEND ME THE REPORT !
Meet Dr K !
Chris Kacher
  • Nuclear physicist
  • Stock & crypto market wizard
  • Blockchain builder
  • Bestselling author
  • Top 40 charted musician
  • Biohacker
  • Former computer hacker
YES, SEND ME THE FILE !
YES, SEND ME BOTH !
Your email will always remain private.

PPR - Pocket Pivots/Buyable Gap-Ups for 4/15/11 - MNTA, AME,

Ametek (AME), posted a buyable gap-up with a 2.27 point move on the open, much larger than its 40-day Average True Range of ... on today's 2.27 of .89 (ATR based on yesterday's close). Volume was 501% above average. Today's low at 43.84 is your guide for a downside stop, allowing for whatever porosity or lack of it that you prefer based on your own risk tolerance.

Momenta Pharmaceuticals (MNTA) is an interesting little bio-tech, and has flashed a couple of pocket pivots, one on March 18th and one today in its pattern as it tries to "round out" the potential lows of a base. The stock is a thinner, smaller bio-tech which therefore carries more risk, and it is expected to announce earnings in early May, which adds additional risk to the name. We might prefer to see how the stock acts after earnings, even it had a big gap-up move as a result of earnings, since this could turn out to be similar to numerous other gap-ups in bio-techs recently. MNTA reminds us a little bit of Jazz Pharmaceuticals back in late October of last year just before it gapped up on earnings. Something for the watch list, in our view, although those who like risk can always take the pocket pivot buy point today at face value using the appropriate selling guide, which we would see as the 50-dma.

This information is provided by MoKa Investors, LLC DBA Virtue of Selfish Investing (VoSI) is issued solely for informational purposes and does not constitute an offer to sell or a solicitation of an offer to buy securities. Information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of available data. VoSI reports are intended to alert VoSI members to technical developments in certain securities that may or may not be actionable, only, and are not intended as recommendations. Past performance is not a guarantee, nor is it necessarily indicative, of future results. Opinions expressed herein are statements of our judgment as of the publication date and are subject to change without notice. Entities including but not limited to VoSI, its members, officers, directors, employees, customers, agents, and affiliates may have a position, long or short, in the securities referred to herein, and/or other related securities, and may increase or decrease such position or take a contra position. Additional information is available upon written request. This publication is for clients of Virtue of Selfish Investing. Reproduction without written permission is strictly prohibited and will be prosecuted to the full extent of the law. ©2024 MoKa Investors, LLC DBA Virtue of Selfish Investing. All rights reserved.
FOR OUR FREE MARKET LAB REPORT :
Copyright ©2024 MoKa Investors, LLC DBA Virtue of Selfish Investing.
All Rights Reserved.
privacy policy